The Effect of Diabetes-Specific Enteral Nutrition Formula on Cardiometabolic Parameters in Patients with Type 2 Diabetes: A Systematic Review and Meta–Analysis of Randomised Controlled Trials

Background: The prevalence of diabetes is on the increase in the UK and worldwide, partly due to unhealthy lifestyles, including poor dietary regimes. Patients with diabetes and other co-morbidities such as stroke, which may affect swallowing ability and lead to malnutrition, could benefit from ente...

Full description

Bibliographic Details
Main Authors: Omorogieva Ojo, Sharon Marie Weldon, Trevor Thompson, Rachel Crockett, Xiao-Hua Wang
Format: Article
Language:English
Published: MDPI AG 2019-08-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/11/8/1905
_version_ 1811335041699020800
author Omorogieva Ojo
Sharon Marie Weldon
Trevor Thompson
Rachel Crockett
Xiao-Hua Wang
author_facet Omorogieva Ojo
Sharon Marie Weldon
Trevor Thompson
Rachel Crockett
Xiao-Hua Wang
author_sort Omorogieva Ojo
collection DOAJ
description Background: The prevalence of diabetes is on the increase in the UK and worldwide, partly due to unhealthy lifestyles, including poor dietary regimes. Patients with diabetes and other co-morbidities such as stroke, which may affect swallowing ability and lead to malnutrition, could benefit from enteral nutrition, including the standard formula (SF) and diabetes-specific formulas (DSF). However, enteral nutrition presents its challenges due to its effect on glycaemic control and lipid profile. Aim: The aim of this review was to evaluate the effectiveness of diabetes-specific enteral nutrition formula versus SF in managing cardiometabolic parameters in patients with type 2 diabetes. Method: This review was conducted in accordance with the preferred reporting items for systematic reviews and meta-analyses. Three databases (Pubmed, EMBASE, PSYCInfo) and Google scholar were searched for relevant articles from inception to 2 January 2019 based on Population, Intervention, Comparator, Outcomes and Study designs (PICOS) framework. Key words, Medical Subject Heading (MeSH) terms, and Boolean operators (AND/OR) formed part of the search strategy. Articles were evaluated for quality and risks of bias. Results: Fourteen articles were included in the systematic review and five articles were selected for the meta-analysis. Based on the findings of the review and meta-analysis, two distinct areas were evident: the effect of DSF on blood glucose parameters and the effect of DSF on lipid profile. All fourteen studies included in the systematic review showed that DSF was effective in lowering blood glucose parameters in patients with type 2 diabetes compared with SF. The results of the meta-analysis confirmed the findings of the systematic review with respect to the fasting blood glucose, which was significantly lower (<i>p</i> = 0.01) in the DSF group compared to SF, with a mean difference of &#8722;1.15 (95% CI &#8722;2.07, &#8722;0.23) and glycated haemoglobin, which was significantly lower (<i>p</i> = 0.005) in the DSF group compared to the SF group following meta-analysis and sensitivity analysis. However, in relation to the sensitivity analysis for the fasting blood glucose, differences were not significant between the two groups when some of the studies were removed. Based on the systematic review, the outcomes of the studies selected to evaluate the effect of DSF on lipid profile were variable. Following the meta-analysis, no significant differences (<i>p</i> &gt; 0.05) were found between the DSF and SF groups with respect to total cholesterol, LDL cholesterol and triglyceride. The level of the HDL cholesterol was significantly higher (<i>p</i> = 0.04) in the DSF group compared to the SF group after the intervention, with a mean difference of 0.09 (95% CI, 0.00, 0.18), although this was not consistent based on the sensitivity analysis. The presence of low glycaemic index (GI) carbohydrate, the lower amount of carbohydrate and the higher protein, the presence of mono-unsaturated fatty acids and the different amounts and types of fibre in the DSF compared with SF may be responsible for the observed differences in cardiometabolic parameters in both groups. Conclusion: The results provide evidence to suggest that DSF is effective in controlling fasting blood glucose and glycated haemoglobin and in increasing HDL cholesterol, but has no significant effect on other lipid parameters. However, our confidence in these findings would be increased by additional data from further studies.
first_indexed 2024-04-13T17:18:07Z
format Article
id doaj.art-0e0fd122a3cd426ca9415375f9590ebe
institution Directory Open Access Journal
issn 2072-6643
language English
last_indexed 2024-04-13T17:18:07Z
publishDate 2019-08-01
publisher MDPI AG
record_format Article
series Nutrients
spelling doaj.art-0e0fd122a3cd426ca9415375f9590ebe2022-12-22T02:38:04ZengMDPI AGNutrients2072-66432019-08-01118190510.3390/nu11081905nu11081905The Effect of Diabetes-Specific Enteral Nutrition Formula on Cardiometabolic Parameters in Patients with Type 2 Diabetes: A Systematic Review and Meta–Analysis of Randomised Controlled TrialsOmorogieva Ojo0Sharon Marie Weldon1Trevor Thompson2Rachel Crockett3Xiao-Hua Wang4Department of Adult Nursing and Paramedic Science, University of Greenwich, London SE9 2UG, UKDepartment of Adult Nursing and Paramedic Science, University of Greenwich, London SE9 2UG, UKDepartment of Psychology, University of Greenwich, London SE10 9LS, UKDivision of Psychology, Faculty of Natural Sciences, University of Stirling, Scotland FK9 4LA, UKThe School of Nursing, Soochow University, Suzhou 215006, ChinaBackground: The prevalence of diabetes is on the increase in the UK and worldwide, partly due to unhealthy lifestyles, including poor dietary regimes. Patients with diabetes and other co-morbidities such as stroke, which may affect swallowing ability and lead to malnutrition, could benefit from enteral nutrition, including the standard formula (SF) and diabetes-specific formulas (DSF). However, enteral nutrition presents its challenges due to its effect on glycaemic control and lipid profile. Aim: The aim of this review was to evaluate the effectiveness of diabetes-specific enteral nutrition formula versus SF in managing cardiometabolic parameters in patients with type 2 diabetes. Method: This review was conducted in accordance with the preferred reporting items for systematic reviews and meta-analyses. Three databases (Pubmed, EMBASE, PSYCInfo) and Google scholar were searched for relevant articles from inception to 2 January 2019 based on Population, Intervention, Comparator, Outcomes and Study designs (PICOS) framework. Key words, Medical Subject Heading (MeSH) terms, and Boolean operators (AND/OR) formed part of the search strategy. Articles were evaluated for quality and risks of bias. Results: Fourteen articles were included in the systematic review and five articles were selected for the meta-analysis. Based on the findings of the review and meta-analysis, two distinct areas were evident: the effect of DSF on blood glucose parameters and the effect of DSF on lipid profile. All fourteen studies included in the systematic review showed that DSF was effective in lowering blood glucose parameters in patients with type 2 diabetes compared with SF. The results of the meta-analysis confirmed the findings of the systematic review with respect to the fasting blood glucose, which was significantly lower (<i>p</i> = 0.01) in the DSF group compared to SF, with a mean difference of &#8722;1.15 (95% CI &#8722;2.07, &#8722;0.23) and glycated haemoglobin, which was significantly lower (<i>p</i> = 0.005) in the DSF group compared to the SF group following meta-analysis and sensitivity analysis. However, in relation to the sensitivity analysis for the fasting blood glucose, differences were not significant between the two groups when some of the studies were removed. Based on the systematic review, the outcomes of the studies selected to evaluate the effect of DSF on lipid profile were variable. Following the meta-analysis, no significant differences (<i>p</i> &gt; 0.05) were found between the DSF and SF groups with respect to total cholesterol, LDL cholesterol and triglyceride. The level of the HDL cholesterol was significantly higher (<i>p</i> = 0.04) in the DSF group compared to the SF group after the intervention, with a mean difference of 0.09 (95% CI, 0.00, 0.18), although this was not consistent based on the sensitivity analysis. The presence of low glycaemic index (GI) carbohydrate, the lower amount of carbohydrate and the higher protein, the presence of mono-unsaturated fatty acids and the different amounts and types of fibre in the DSF compared with SF may be responsible for the observed differences in cardiometabolic parameters in both groups. Conclusion: The results provide evidence to suggest that DSF is effective in controlling fasting blood glucose and glycated haemoglobin and in increasing HDL cholesterol, but has no significant effect on other lipid parameters. However, our confidence in these findings would be increased by additional data from further studies.https://www.mdpi.com/2072-6643/11/8/1905diabetes specific formulastandard formulatype 2 diabetesenteral nutritionenteral tube feedinglipidsfasting blood glucoseglycated haemoglobin
spellingShingle Omorogieva Ojo
Sharon Marie Weldon
Trevor Thompson
Rachel Crockett
Xiao-Hua Wang
The Effect of Diabetes-Specific Enteral Nutrition Formula on Cardiometabolic Parameters in Patients with Type 2 Diabetes: A Systematic Review and Meta–Analysis of Randomised Controlled Trials
Nutrients
diabetes specific formula
standard formula
type 2 diabetes
enteral nutrition
enteral tube feeding
lipids
fasting blood glucose
glycated haemoglobin
title The Effect of Diabetes-Specific Enteral Nutrition Formula on Cardiometabolic Parameters in Patients with Type 2 Diabetes: A Systematic Review and Meta–Analysis of Randomised Controlled Trials
title_full The Effect of Diabetes-Specific Enteral Nutrition Formula on Cardiometabolic Parameters in Patients with Type 2 Diabetes: A Systematic Review and Meta–Analysis of Randomised Controlled Trials
title_fullStr The Effect of Diabetes-Specific Enteral Nutrition Formula on Cardiometabolic Parameters in Patients with Type 2 Diabetes: A Systematic Review and Meta–Analysis of Randomised Controlled Trials
title_full_unstemmed The Effect of Diabetes-Specific Enteral Nutrition Formula on Cardiometabolic Parameters in Patients with Type 2 Diabetes: A Systematic Review and Meta–Analysis of Randomised Controlled Trials
title_short The Effect of Diabetes-Specific Enteral Nutrition Formula on Cardiometabolic Parameters in Patients with Type 2 Diabetes: A Systematic Review and Meta–Analysis of Randomised Controlled Trials
title_sort effect of diabetes specific enteral nutrition formula on cardiometabolic parameters in patients with type 2 diabetes a systematic review and meta analysis of randomised controlled trials
topic diabetes specific formula
standard formula
type 2 diabetes
enteral nutrition
enteral tube feeding
lipids
fasting blood glucose
glycated haemoglobin
url https://www.mdpi.com/2072-6643/11/8/1905
work_keys_str_mv AT omorogievaojo theeffectofdiabetesspecificenteralnutritionformulaoncardiometabolicparametersinpatientswithtype2diabetesasystematicreviewandmetaanalysisofrandomisedcontrolledtrials
AT sharonmarieweldon theeffectofdiabetesspecificenteralnutritionformulaoncardiometabolicparametersinpatientswithtype2diabetesasystematicreviewandmetaanalysisofrandomisedcontrolledtrials
AT trevorthompson theeffectofdiabetesspecificenteralnutritionformulaoncardiometabolicparametersinpatientswithtype2diabetesasystematicreviewandmetaanalysisofrandomisedcontrolledtrials
AT rachelcrockett theeffectofdiabetesspecificenteralnutritionformulaoncardiometabolicparametersinpatientswithtype2diabetesasystematicreviewandmetaanalysisofrandomisedcontrolledtrials
AT xiaohuawang theeffectofdiabetesspecificenteralnutritionformulaoncardiometabolicparametersinpatientswithtype2diabetesasystematicreviewandmetaanalysisofrandomisedcontrolledtrials
AT omorogievaojo effectofdiabetesspecificenteralnutritionformulaoncardiometabolicparametersinpatientswithtype2diabetesasystematicreviewandmetaanalysisofrandomisedcontrolledtrials
AT sharonmarieweldon effectofdiabetesspecificenteralnutritionformulaoncardiometabolicparametersinpatientswithtype2diabetesasystematicreviewandmetaanalysisofrandomisedcontrolledtrials
AT trevorthompson effectofdiabetesspecificenteralnutritionformulaoncardiometabolicparametersinpatientswithtype2diabetesasystematicreviewandmetaanalysisofrandomisedcontrolledtrials
AT rachelcrockett effectofdiabetesspecificenteralnutritionformulaoncardiometabolicparametersinpatientswithtype2diabetesasystematicreviewandmetaanalysisofrandomisedcontrolledtrials
AT xiaohuawang effectofdiabetesspecificenteralnutritionformulaoncardiometabolicparametersinpatientswithtype2diabetesasystematicreviewandmetaanalysisofrandomisedcontrolledtrials